ETX.L - e-Therapeutics plc

LSE - LSE Delayed Price. Currency in GBp
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in GBP. All numbers in thousands
Revenue1/31/20191/31/20181/31/20171/31/2016
Total Revenue44---
Cost of Revenue----
Gross Profit44---
Operating Expenses
Research Development3,6735,01910,9119,965
Selling General and Administrative1,4851,6292,0621,590
Non Recurring----
Others----
Total Operating Expenses5,1586,64812,97311,555
Operating Income or Loss-5,114-6,648-12,973-11,555
Income from Continuing Operations
Total Other Income/Expenses Net29-71-3,225271
Earnings Before Interest and Taxes-5,114-6,648-12,973-11,555
Interest Expense----
Income Before Tax-5,085-6,719-16,198-11,284
Income Tax Expense-1,086-1,360-3,073-2,464
Minority Interest----
Net Income From Continuing Ops-3,999-5,359-13,125-8,820
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-3,999-5,359-13,125-8,820
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-3,999-5,359-13,125-8,820